MapLight Therapeutics: Chief medical officer Erin Pennock sold 15,355 shares

What happened

• Erin Pennock, chief medical officer, sold 15,355 shares in an open-market transaction on Oct 15, 2026, for total proceeds of $124,068. The filing reports a weighted average price of $8.08.

Key details

• Transaction date and price: Oct 15, 2026; weighted average price $8.08; individual sale prices ranged from $7.755 to $8.3732.
• Transaction type: sale (code S).
• Shares disposed: 15,355 shares for $124,068.
• Shares owned after the transaction: not reported in the Form 4 provided.
• Filing date: Oct 16, 2026 (reporting period Oct 15, 2026).
• Footnote F1: shares sold to cover statutory tax withholding on vested restricted stock units; the sale was mandated by the issuer's "sell to cover" election and is not a discretionary sale by the reporting person.
• Footnote F2: the $8.08 price is a weighted average; the reporting person can provide a breakdown of the number of shares sold at each price within the $7.755 to $8.3732 range upon request.

Why it may matter

• The filing shows a sell-to-cover for tax withholding related to vesting of restricted stock units, not a voluntary, discretionary sale by the insider.
• This filing does not show why the insider traded or why the company acted.